项目编号 PRJCA022206
项目标题 Urine metabolomics phenotyping in mild cognitive impairment and Alzheimer's disease
涉及领域 Medical
数据类型 metabolomics
物种名称 Homo sapiens
描述信息 Alzheimer's disease is a prevalent disease with a heavy global burden and is suggested to be a metabolic disease in the brain in recent years. The metabolome is considered to be the most promising phenotype which reflects changes in genetic, transcript, and protein profiles as well as environmental effects. Aiming to obtain a comprehensive understanding and convenient diagnosis of MCI and AD from another perspective, researchers are working on AD metabolomics. Urine is more convenient which could reflect the change of disease at an earlier stage. Thus, we conducted a cross-sectional study to investigate urine metabolomics during AD continuum. We enrolled participants from China-Japan Friendship Hospital from April 2022 to November 2022, collected urine samples and conducted an LC-MS/MS analysis. Fifty-seven AD patients, 43 MCI patients and 62 CN subjects were enrolled. A total of 2140 metabolites were identified.
样品范围 Multiisolate
发布日期 2023-12-19
出版信息
PubMed ID 文章标题 杂志名称 Doi 发表年份
Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer's disease Frontiers in aging neuroscience 10.3389/fnagi.2023.1273807
38187356 Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer’s disease Frontiers in Aging Neuroscience 10.3389/fnagi.2023.1273807 2023
项目资金来源
机构 项目类型 授权项目ID 授权项目名称
National Natural Science Foundation of China (NSFC) 81974220
提交者 Yuye Wang (pumcwyy@126.com)
提交单位 China-Japan Friendship Hospital
提交日期 2023-12-19

项目包含数据信息

资源名称 描述